Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Enterprise Value: 2010-2025

Historic Enterprise Value for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $72.4 million.

  • Ironwood Pharmaceuticals' Enterprise Value fell 87.30% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year decrease of 186.76%. This contributed to the annual value of $620.4 million for FY2024, which is 63.38% down from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Enterprise Value stood at $72.4 million, which was up 211.92% from $23.2 million recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Enterprise Value high stood at $1.7 billion for Q4 2023, and its period low was $23.2 million during Q2 2025.
  • For the 3-year period, Ironwood Pharmaceuticals' Enterprise Value averaged around $820.6 million, with its median value being $880.2 million (2023).
  • Its Enterprise Value has fluctuated over the past 5 years, first spiked by 41.09% in 2024, then tumbled by 97.51% in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' Enterprise Value (Quarterly) stood at $1.3 billion in 2021, then dropped by 3.39% to $1.2 billion in 2022, then soared by 36.27% to $1.7 billion in 2023, then plummeted by 63.38% to $620.4 million in 2024, then slumped by 87.30% to $72.4 million in 2025.
  • Its last three reported values are $72.4 million in Q3 2025, $23.2 million for Q2 2025, and $129.4 million during Q1 2025.